Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2921 - Phase II Study of Low Dose Bridging Radiotherapy prior to Axicabtagene-Ciloleucel in Patients with Relapsed/Refractory Follicular Lymphoma
Presenter(s)
Susan Wu, MD - MD Anderson Cancer Center, Houston, TX